The catastrophic antiphospholipid (Asherson's) syndrome and malignancies
W Miesbach1, R A Asherson, R Cervera
1Department of Internal Medicine III, University Hospital, Johan Wolfgang Goethe-University, Theodor-Stern-Kai 7, 60590 Frankfurt/Main, Germany. miesbach@em.uni-frankfurt.de
Malignancy is a significant risk factor for catastrophic antiphospholipid syndrome (APS), a rare but severe condition. In 9% of cases, cancer or related surgeries precipitated catastrophic APS, often involving cerebral complications.
Area of Science:
- Rheumatology
- Oncology
- Hematology
Background:
- Catastrophic antiphospholipid syndrome (APS) is a severe condition characterized by rapid thrombotic events, often linked to underlying malignancies.
- Understanding the interplay between malignancy and catastrophic APS is crucial for early diagnosis and management.
Purpose of the Study:
- To evaluate the clinical characteristics of patients with catastrophic APS and associated malignancies.
- To identify the role of malignancy as a precipitating factor in catastrophic APS.
Main Methods:
- Analysis of a web-based international registry of patients with catastrophic APS.
- Evaluation of clinical data, including associated malignancies and precipitating factors, for 262 patients.
Main Results:
- Of 262 patients, 23 (9%) had associated malignancies, including hematological cancers (26%), lung carcinoma (17%), and colon carcinoma (9%).
- Malignancy was the precipitating factor in 61% of these cases; surgical procedures related to cancer precipitated catastrophic APS in 17%.
- Cerebral manifestations (infarcts, encephalopathy) were most common; recovery occurred in 39% of patients with malignancy.
Conclusions:
- Malignancy represents an important risk factor for developing catastrophic APS.
- Cancer and associated surgical interventions frequently precipitate catastrophic APS, highlighting the need for vigilance in oncology patients.
Related Concept Videos
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Pancreatitis II: Pathophysiology
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
